Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
Status:
Withdrawn
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antiemetic drugs, such as aprepitant and ondansetron, may help lessen nausea and
vomiting caused by opioids. It is not yet known whether aprepitant is more effective than
ondansetron in treating nausea and vomiting caused by opioids in patients with cancer.
PURPOSE: This randomized clinical trial is studying aprepitant to see how well it works
compared to ondansetron in treating nausea and vomiting caused by opioids in patients with
cancer.